XML 153 R141.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplemental Disclosures of Cash Flow Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Supplemental disclosures of cash flow information:      
Cash and cash equivalents $ 1,424 $ 1,262 $ 4,486
Fiduciary funds (included in fiduciary assets) 2,368 3,459 3,203
Cash and cash equivalents and fiduciary funds (included in current assets held for sale) 0 0 2
Total cash, cash equivalents and restricted cash 3,792 4,721 7,691
Increase/(decrease) in cash, cash equivalents and other restricted cash [1] (940) (2,806) 1,517
Cash payments for income taxes, net 348 428 570
Cash payments for interest 223 201 212
Cash acquired 0 30 5
Supplemental disclosures of non-cash investing and financing activities:      
Non-cash consideration received 0 63 0
Fair value of deferred and contingent consideration related to acquisitions 3 28 21
Non-Fiduciary [Member]      
Supplemental disclosures of cash flow information:      
Increase/(decrease) in cash, cash equivalents and other restricted cash 163 (3,177) 2,425
Fiduciary [Member]      
Supplemental disclosures of cash flow information:      
Increase/(decrease) in cash, cash equivalents and other restricted cash $ (1,103) $ 371 $ (908)
[1] The amounts of cash, cash equivalents and restricted cash, their respective classification on the consolidated balance sheets as well as their respective portions of the increase or decrease in cash, cash equivalents and restricted cash for each of the periods presented have been included in Note 21 Supplemental Disclosures of Cash Flow Information.